The FDA has approved delgocitinib cream as a topical treatment for moderate-to-severe chronic hand eczema (CHE) in adults, ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA. The agency approved ...

As someone who has dedicated decades of their life to finding solutions for the chronic eczema and severely dry skin on my hands, it’s surprising that I only just learned about Gloves in a Bottle, a ...

Delgocitinib is a JAK inhibitor that blocks the activation of the JAK-STAT pathway which has been shown to play a key role in the pathophysiology of chronic inflammatory skin diseases.

The topical JAK inhibitor is the first treatment approved specifically for adults with moderate-to-severe chronic hand eczema.

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...